New hope for kids with Crohn's: testing a powerful drug combo
NCT ID NCT07424040
Summary
This study aims to find out if giving two drugs together (infliximab and azathioprine) works better and is as safe as giving just one drug (infliximab) for children with active Crohn's disease. Researchers will compare how well each treatment reduces gut inflammation and controls symptoms over a year. The goal is to help doctors choose the best long-term treatment to improve kids' health and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
JinHua Maternal & Child Health Care Hospital
Jinhua, Zhejiang, 321000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Children's Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First People's Hospital of Yunnan
Kunming, Yunnan, 650000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.